Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Símbolo desconocido
Fecha:
Ordernar por:
FechaHoraFuenteTítuloSímboloCompañía
29/07/202406:05GlobeNewswire Inc.NEIRO, a Meme Coin, Will Be Initially Listed on CoinW Exchange
29/07/202406:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:CAMTCamtek Ltd
29/07/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MSGMMotorsport Games Inc
29/07/202406:05Business WireAspen Appoints Christian Dunleavy as Group President and Mark Pickering as Group Chief Financial Officer & TreasurerASX:AHLAdrad Holdings Ltd
29/07/202406:05Business WireBruce Sherrick Joins Farmland Partners Board of DirectorsNYSE:FPIFarmland Partners Inc
29/07/202406:04Business WireLegalShield Workplace Study Unearths Gaps in Employee-Employer Expectations About Benefits Value, Communication
29/07/202406:03GlobeNewswire Inc.PUPPIES, a Meme Coin, Will Be Listed on CoinW Exchange
29/07/202406:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:PMPhilip Morris International Inc
29/07/202406:03PR Newswire (US)Taylor Morrison and Extreme Makeover: Home Edition Enlist Community Volunteers to Help Build New Home for Local Houston FamilyNYSE:TMHCTaylor Morrison Home Holding Company
29/07/202406:02Alliance NewsAlliance NewsLONDON MARKET MIDDAY: Stocks rise but BoE cut hopes temper pound
29/07/202406:02GlobeNewswire Inc.Ocugen to Host Conference Call on Thursday, August 8 at 8:30 A.M. ET to Discuss Business Updates and Second Quarter 2024 Financial ResultsNASDAQ:OCGNOcugen Inc
29/07/202406:01Alliance NewsAlliance NewsIN BRIEF: Concurrent Technologies launches new Plug In CardLSE:CNCConcurrent Technologies Plc
29/07/202406:01GlobeNewswire Inc.LuxUrban Hotels Announces Agreement in Principle to Issue Up to $5.0 Million Senior Notes Due 2027NASDAQ:LUXHLuxUrban Hotels Inc
29/07/202406:01Business WireRapid Finance Adds Matthew Thomas as Enterprise Account Executive
29/07/202406:01PR Newswire (US)Syndax Announces PDUFA Action Date Extension for Revumenib NDA for Relapsed or Refractory KMT2Ar Acute LeukemiaNASDAQ:SNDXSyndax Pharmaceuticals Inc
29/07/202406:01PR Newswire (US)Leading Midsize Agency, /prompt. Announces Significant Investment in Augmented Intelligence-Powered Strategy Team
29/07/202406:01PR Newswire (US)Tech Mahindra Positioned as a Service Leader in the 2024 SPARK Matrix™ Contact Center Outsourcing Services by Quadrant Knowledge Solutions
29/07/202406:00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:CVMCel Sci Corporation New
29/07/202406:00GlobeNewswire Inc.AMG Reports Financial and Operating Results for the Second Quarter and First Half of 2024NYSE:AMGAffiliated Managers Group Inc
29/07/202406:00Business WireParticular Audience Named in The Leading 100 List, Setting a New Standard in AI-Driven Hyper-Personalization for eCommerce & Retail Media
29/07/202406:00GlobeNewswire Inc.Manhattan Bridge Capital, Inc. Declares Quarterly DividendNASDAQ:LOANManhattan Bridge Capital Inc
29/07/202406:00Business WireNOG Provides Shareholder Return Update; Plans Mid-Year Increase to Quarterly DividendNYSE:NOGNorthern Oil and Gas Inc
29/07/202406:00Business WireSarepta Therapeutics to Announce Second Quarter 2024 Financial ResultsNASDAQ:SRPTSarepta Therapeutics Inc New
29/07/202406:00GlobeNewswire Inc.ECARX Announces Board ChangeNASDAQ:ECXECARX Holdings Inc
29/07/202406:00Business WireVirginia State Parks Becomes First in the Nation to Install EnChroma-adapted Viewfinders for Colorblind Guests at Every Park
29/07/202406:00GlobeNewswire Inc.CorVascular’s VasoGuard® Earns FDA 510(k) Clearance
29/07/202406:00Business WireMyrobalan Therapeutics Names Grant Bogle to Board of Directors
29/07/202406:00Business WireGoldenTree Asset Management Hires Head of Real Estate Credit Origination
29/07/202406:00GlobeNewswire Inc.Attralus Receives European Medicines Agency Committee for Orphan Medicinal Products (COMP) Positive Opinions for AT-02 for the Treatment of Both ATTR and AL Amyloidosis
29/07/202406:00Business WireSpear Bio Secures $45 Million in Oversubscribed Series A Financing to Accelerate Product Launch for Protein Research and Disease Diagnostics